Showing results (351-360 of 572) with videos related to
Sort By:
Pageof 58
European Heart Journal. Acute Cardiovascular Care|April 8, 2026
Prognostic Value of QRS Duration in Acute Myocarditis: Insights from a Multicenter Cohort StudyJihee Son, Jihoon Kim, David Hong, et al.ESMO Open|November 16, 2016
Cancer clinical research in Latin America: current situation and opportunities. Expert opinion from the first ESMO workshop on clinical trials, Lima, 2015Christian Rolfo, Christian Caglevic, Denisse Bretel, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|January 24, 2020
Design, synthesis and α-glucosidase inhibition study of novel embelin derivativesXiaole Chen, Min Gao, Rongchao Jian, et al.Journal of Neurosurgery. Pediatrics|August 3, 2019
Arterial spin labeling perfusion changes of the frontal lobes in children with posterior fossa syndromeDerek Yecies, Katie Shpanskaya, Rashad Jabarkheel, et al.Investigational New Drugs|June 6, 2009
A phase I trial of imexon, a pro-oxidant, in combination with docetaxel for the treatment of patients with advanced breast, non-small cell lung and prostate cancerStacy Moulder, Navneet Dhillon, Chaan Ng, et al.BJU International|July 6, 2021
Definitive radiotherapy for extracranial oligoprogressive metastatic renal cell carcinoma as a strategy to defer systemic therapy escalationBrian De, Aradhana M Venkatesan, Pavlos Msaouel, et al.Future Oncology (London, England)|September 11, 2024
Focal therapy for oligometastatic and oligoprogressive renal cell carcinoma: a narrative reviewAugust C Anderson, Joel Ho, Evan T Hall, et al.Cancer|January 29, 2010
Phase 1 pharmacokinetic and drug-interaction study of dasatinib in patients with advanced solid tumorsFaye M Johnson, Shruti Agrawal, Howard Burris, et al.The Journal of Clinical Endocrinology and Metabolism|October 13, 2009
Phase I clinical trials in 56 patients with thyroid cancer: the M. D. Anderson Cancer Center experienceApostolia Maria Tsimberidou, Christos Vaklavas, Sijin Wen, et al.Cancer|February 17, 2021
Five-year outcomes from a prospective comparative effectiveness study evaluating external-beam radiotherapy with or without low-dose-rate brachytherapy boost for localized prostate cancerDario Pasalic, Daniel A Barocas, Li-Ching Huang, et al.Pageof 58